Literature DB >> 20512046

Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.

Sarit A Golub1, William Kowalczyk, Corina L Weinberger, Jeffrey T Parsons.   

Abstract

OBJECTIVES: Preexposure prophylaxis (PREP) is an emerging HIV prevention strategy; however, many fear it may lead to neglect of traditional risk reduction practices through behavioral disinhibition or risk compensation.
METHODS: Participants were 180 HIV-negative high-risk men who have sex with men recruited in New York City, who completed an Audio Computer Assisted Self Interview-administered survey between September 2007 and July 2009. Bivariate and multivariate logistic regression models were used to predict intention to use PREP and perceptions that PREP would decrease condom use.
RESULTS: Almost 70% (n = 124) of participants reported that they would be likely to use PREP if it were at least 80% effective in preventing HIV. Of those who would use PREP, over 35% reported that they would be likely to decrease condom use while on PREP. In multivariate analyses, arousal/pleasure barriers to condom use significantly predicted likelihood of PREP use (odds ratio = 1.71, P < 0.05) and risk perception motivations for condom use significantly predicted decreased condom use on PREP (odds ratio = 2.48, P < 0.05). DISCUSSION: These data provide support for both behavioral disinhibition and risk compensation models and underscore the importance of developing behavioral interventions to accompany any wide-scale provision of PREP to high-risk populations.

Entities:  

Mesh:

Year:  2010        PMID: 20512046      PMCID: PMC2908204          DOI: 10.1097/QAI.0b013e3181e19a54

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  29 in total

Review 1.  Risk compensation: the Achilles' heel of innovations in HIV prevention?

Authors:  Michael M Cassell; Daniel T Halperin; James D Shelton; David Stanton
Journal:  BMJ       Date:  2006-03-11

Review 2.  Pre-exposure prophylaxis for HIV infection: what if it works?

Authors:  Lynn A Paxton; Tony Hope; Harold W Jaffe
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

3.  Disinhibition and risk compensation: scope, definitions, and perspective.

Authors:  Matthew Hogben; Nicole Liddon
Journal:  Sex Transm Dis       Date:  2008-12       Impact factor: 2.830

4.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

5.  Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

Authors:  K K Van Rompay; M B McChesney; N L Aguirre; K A Schmidt; N Bischofberger; M L Marthas
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

6.  Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men.

Authors:  David E Ostrow; Kelly J Fox; Joan S Chmiel; Anthony Silvestre; Barbara R Visscher; Peter A Vanable; Lisa P Jacobson; Steffanie A Strathdee
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

7.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

8.  Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Authors:  Jeffrey N Martin; Michelle E Roland; Torsten B Neilands; Melissa R Krone; Joshua D Bamberger; Robert P Kohn; Margaret A Chesney; Karena Franses; James O Kahn; Thomas J Coates; Mitchell H Katz
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

9.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

10.  The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.

Authors:  Debby C J Vissers; Hélène A C M Voeten; Nico J D Nagelkerke; J Dik F Habbema; Sake J de Vlas
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more
  135 in total

Review 1.  Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.

Authors:  Kellie Freeborn; Carmen J Portillo
Journal:  J Clin Nurs       Date:  2018-09       Impact factor: 3.036

2.  The Peltzman effect and compensatory markers in medicine.

Authors:  Vinay Prasad; Anupam B Jena
Journal:  Healthc (Amst)       Date:  2014-09-01

3.  Will risk compensation accompany pre-exposure prophylaxis for HIV?

Authors:  Jill Blumenthal; Richard H Haubrich
Journal:  Virtual Mentor       Date:  2014-11-01

4.  The ART of preventing HIV.

Authors: 
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

5.  Differences in Attitudes About HIV Pre-Exposure Prophylaxis Use Among Stimulant Versus Alcohol Using Men Who Have Sex with Men.

Authors:  Catherine E Oldenburg; Jennifer A Mitty; Katie B Biello; Elizabeth F Closson; Steven A Safren; Kenneth H Mayer; Matthew J Mimiaga
Journal:  AIDS Behav       Date:  2016-07

6.  Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.

Authors:  Michael E Newcomb; Kevin Moran; Brian A Feinstein; Emily Forscher; Brian Mustanski
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

7.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

8.  Threefold Increase in PrEP Uptake Over Time with High Adherence Among Young Men Who Have Sex With Men in Chicago.

Authors:  Ethan Morgan; Kevin Moran; Daniel T Ryan; Brian Mustanski; Michael E Newcomb
Journal:  AIDS Behav       Date:  2018-11

Review 9.  HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.

Authors:  Marianne Martinello; Behzad Hajarizadeh; Jason Grebely; Gregory J Dore; Gail V Matthews
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

10.  Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study.

Authors:  Rafael E Pérez-Figueroa; Farzana Kapadia; Staci C Barton; Jessica A Eddy; Perry N Halkitis
Journal:  AIDS Educ Prev       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.